Get a glimpse into our company and investor data—powered by the PitchBook Platform
Early Stage VCLATEST DEAL TYPE
$1.05MLATEST DEAL AMOUNT
Operator of a bio-pharmaceutical company. The company is focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine.